CRT 2025
CRT Beyond the Guidelines
DAPT
Dominick J. Angiolillo, MD, PhD, FSCAI
Professor of Medicine
University of Florida College of Medicine - Jacksonville
Jacksonville, Florida, United States
Disclosure(s): No financial relationships to disclose
Usman Baber, MD, MS
Professor of Medicine
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
Disclosure information not submitted.
Douglas E. Drachman, MD, MSCAI
Director of Education and Director of Interventional Cardiology Fellowship Program
Massachusetts General Hospital
Boston, Massachusetts, United States
Disclosure(s): No financial relationships to disclose
Paul A. Gurbel, MD, FSCAI
Director
Sinai Center for Thrombosis Research and Drug Development
Baltimore, Maryland, United States
Disclosure information not submitted.
Adnan Kastrati, MD
Senior Consultant, Head of Catheterization Laboratory
Deutsches Herzzentrum Muenchen
Munich, Bayern, Germany
Disclosure(s): No financial relationships to disclose
Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, MSCAI
Professor of Cardiology and Population Health Science and Policy, Mount Sinai Endowed Professor in Cardiovascular Clinical Research and Outcomes;
Director of Interventional Cardiovascular Research and Clinical Trials;
Director of Women’s Heart and Vascular Center at Mount Sinai Heart
Icahn School of Medicine at Mount Sinai, New York
New York, New York, United States
Disclosure(s): Abbott, Alleviant Medical, Beth Israel Deaconess Medical Center, Concept Medical, Cordis, Elixir Medical, Faraday Pharmaceuticals, Idorsia Pharmaceuticals, Janssen, MedAlliance, Mediasphere Medical, Medtronic, Novartis, Protembis GmbH, Sanofi, RM Glo: Grant/Research Support (Ongoing); AMA - JAMA Cardiology (Associate Editor), ACC (BOT Member, SC Member CTR Program): Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Elixir Medical, Stel, ControlRad (spouse): Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Elixir Medical, IQVIA, Medtronic, Medscape/WebMD Global, NovoNordisk: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); SCAI (Women in Innovations Committee Member), Faculty Cardiovascular Research Foundation (CRF), Women as One (Founding Director): SCAI (Women in Innovations Committee Member), Faculty Cardiovascular Research Foundation (CRF), Women as One (Founding Director) (Ongoing)
Grant W. Reed, MD, MSc
Program Director, Interventional Cardiology Fellowship
Cleveland Clinic
Cleveland, Ohio, United States
Disclosure(s): Abbott Laboratories: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)